About the Company
Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company's products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company'sproducts are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
|Name||Ticker||Market Capitalization (USD M)||Revenue (USD M)||Price/Book||Price/Earning||Net Margin (%)|
|Conversion Labs Inc||CVLB||108548||35213||3.74||42.66||7.33|
|Royalty Pharma plc||RPRX||18925||2239||2.81||15.20||43.40|
|Organon & Co.||OGN||8905||7891||-4.60||5.10||22.06|
|ATAI Life Sciences N.V.||ATAI||2272||20||4.78||-10.40||-932.88|
|Cronos Group Inc||CRON||2097||57||1.32||-14.52||-258.59|
|Usana Health Sciences Inc||USNA||2079||1254||4.73||14.98||11.09|
|NRX Pharmaceuticals Inc||NRXP||1170||2321||0.45||5.05||9.91|
|Phathom Pharmaceuticals Inc||PHAT||1033||7.01||-6.45||None|
|Phibro Animal Health Corp.||PAHC||893||833||3.70||16.25||6.53|
|Intersect ENT Inc||XENT||893||103||21.65||-13.01||-66.55|
|Edgewise Therapeutics Inc||EWTX||796||2.70||-29.55||None|
|Fulcrum Therapeutics Inc||FULC||711||15||8.62||-9.63||-481.07|
|Pliant Therapeutics Inc||PLRX||614||13||2.51||-7.16||-613.56|
|Cyteir Therapeutics Inc||CYT||596||3.20||-20.62||None|
|Urovant Sciences Ltd||UROV||503||-3.65||-3.08||None|
|Ikena Oncology Inc||IKNA||404||10||2.18||-7.38||-551.28|
|Provention Bio Inc||PRVB||377||2.53||-2.94||None|
|Rain Therapeutics Inc||RAIN||355||413||2.19||-11.66||123.20|
|Verrica Pharmaceuticals Inc||VRCA||325||12||6.57||-8.92||-301.45|
|Adicet Bio Inc||ACET||280||9||1.22||-4.97||-603.06|
|Terns Pharmaceuticals Inc||TERN||252||1.40||-7.30||None|
|Milestone Pharmaceuticals Inc||MIST||219||15||1.23||-7.37||-215.93|
|Kaleido Biosciences Inc||KLDO||184||1||4.11||-2.07||None|
|Citius Pharmaceuticals Inc||CTXR||179||2.24||-7.81||None|
|Aquestive Therapeutics Inc||AQST||142||42||-2.95||-2.21||-152.73|
|Eton Pharmaceuticals Inc||ETON||124||15||6.13||-10.10||-74.52|
|Osmotica Pharmaceuticals Plc||OSMT||122||190||2.37||-1.31||-47.85|
|Kala Pharmaceuticals Inc||KALA||119||11||1.53||-0.94||None|
|Xeris Biopharma Holdings Inc||XERS||111||34||12.19||-1.44||-248.46|
|Odonate Therapeutics Inc||ODT||110||1.39||-0.94||None|
|Anebulo Pharmaceuticals Inc||ANEB||102||7.93||-2.58||None|
|Opiant Pharmaceuticals Inc||OPNT||100||37||3.03||-96.15||-3.06|
|Aerpio Pharmaceuticals Inc||ARPO||99||15||2.98||-5.24||-28.77|
|Natural Alternatives Internati||NAII||80||179||1.07||7.90||6.03|
|India Globalization Capital In||IGC||67||0||2.45||-7.60||-981.18|
|VYNE Therapeutics Inc||VYNE||51||16||0.77||2.31||-554.66|
|Assertio Holdings Inc||ASRT||36||117||0.49||-0.63||-38.05|
|Dermata Therapeutics Inc||DRMA||36||-75.67||-7.32||None|
|Acasti Pharma Inc||ACST||33||0||1.43||-1.66||-611.47|
|Nabriva Therapeutics Plc||NBRV||29||12||0.88||-0.49||-452.55|
|Lexaria Bioscience Corp||LEXX||27||1||3.76||-6.95||-445.15|
|Bio-Path Holdings Inc||BPTH||26||0||1.19||-2.49||18.96|
|Reviva Pharmaceuticals Holding||RVPH||25||1.41||-4.08||None|
|Baudax Bio Inc||BXRX||25||1||-10.80||0.76||9.10|
|Trevi Therapeutics Inc||TRVI||23||1.64||-0.66||None|
|Timber Pharmaceuticals Inc||TMBR||20||0||8.79||0.68||-527.55|
|Hoth Therapeutics Inc||HOTH||19||1.64||-2.02||None|
|Sonoma Pharmaceuticals Inc.||SNOA||11||17||3.32||-2.16||-31.96|
During the recent session, Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA)’s traded shares were 18.65 million, with the beta value ...
Sonoma Pharmaceuticals Inc. (SNOA) market price of $6.27 offers the impression of an exciting value play
At the end of the latest market close, Sonoma Pharmaceuticals Inc. (SNOA) was valued at $5.94. In that particular session, Stock kicked-off at the price of $7.08 while reaching the peak value of $7.20 ...
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) traded at $6.27 at close of the session on Friday, 10/15/21, made an upward move of 5.56% on its previous day’s price. Looking at the stock we see that its ...
Sonoma Pharmaceuticals Inc. (SNOA) Profit Margins posted -32.00% in the last twelve months: The key fundamentals to watch
For the readers interested in the stock health of Sonoma Pharmaceuticals Inc. (SNOA). It is currently valued at $6.26. When the transactions were called off in the previous session, Stock hit the ...
Sonoma Pharmaceuticals Inc. (SNOA) and its partner, the MicroSafe Group said in a statement. In Friday pre-market trade, SNOA was trading at $7.21 up $1.27 or 21.38%. The Australia has approved ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) and its partner, the MicroSafe Group, announced that the Australian Therapeutic Goods Administration has approved extended claims for Nanocyn ...
Swift, Uneventful Sonoma County Winegrape Harvest Is A Welcome Change And May Signal Return Of Market Balance
In a year best described as a "cold start to a warm, fast finish," reports from throughout Sonoma County indicate that the harvest was a little early, the grape yield appears to be slightly ...